Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
They continue to look for growth opportunities globally.
Quelle est la meilleure partie de votre programme de rémunération?
Our health, dental, and vision benefits our good!
Qu’est-ce qui vous rend le plus heureux au travail?
Helping patients through collaboration and problem solving and my team.
Quelles sont les meilleures choses à propos de votre équipe?
My team is the best! They are hard working, collaborative, fun, and always doing what they can to help patients.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
My team and my manager are very supportive. We always look to encourage each other and collaborate. My manager cares about me and my personal development.
Other Employee Reviews for Karyopharm Therapeutics
×